Professor | Youqian Wu | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Youqian Wu

Contact Information

youqianw@zju.edu.cn

Language ability

Chinese, English

Province

Zhejiang

University/Lab Affiliation and Title	Zhejiang University
Faculty	Medical
Academic Background & Achievements	2013-2016 Master of Science: Zhejiang University, College of Life Sciences 2016-2019 Doctor of Science: Zhejiang University, School of Medicine Research on PD-L1 protein degradation pathways Established high-throughput drug screening model based on PD-L1 membrane protein Identified new E3 ubiquitin ligase ARIH1 for PD-L1 protein Discovered new mechanism of EGFR-GSK3α-ARIH1 pathway in tumor immunity Received Chinese invention patent for combination drug targeting EGFR resistance mutation C797S in lung cancer
Work Experience	2013-2016 - Zhejiang University, College of Life Sciences - Master's Student 2016-2019 - Zhejiang University, School of Medicine - Doctoral Student 2019-2021 - Zhejiang University, School of Medicine - Postdoctoral Researcher in Tumor Immunotherapy 2021.07-present - Zhejiang University, Fourth Affiliated Hospital - Associate Researcher

University/Lab Affiliation and Title

Zhejiang University

Faculty

Medical

Academic Background & Achievements

2013-2016 Master of Science: Zhejiang University, College of Life Sciences
2016-2019 Doctor of Science: Zhejiang University, School of Medicine
Research on PD-L1 protein degradation pathways
Established high-throughput drug screening model based on PD-L1 membrane protein
Identified new E3 ubiquitin ligase ARIH1 for PD-L1 protein
Discovered new mechanism of EGFR-GSK3α-ARIH1 pathway in tumor immunity
Received Chinese invention patent for combination drug targeting EGFR resistance mutation C797S in lung cancer

Work Experience

2013-2016 - Zhejiang University, College of Life Sciences - Master's Student
2016-2019 - Zhejiang University, School of Medicine - Doctoral Student
2019-2021 - Zhejiang University, School of Medicine - Postdoctoral Researcher in Tumor Immunotherapy
2021.07-present - Zhejiang University, Fourth Affiliated Hospital - Associate Researcher

Areas of Focus	Tumor Immunotherapy and New Target Drug Development Asthma and Airway Inflammation Immunotherapy

Areas of Focus

Tumor Immunotherapy and New Target Drug Development
Asthma and Airway Inflammation Immunotherapy

Tumor Immunotherapy New Target Drug Asthma Airway Inflammation Pd-L1 Egfr Gsk3Α Arih1 Lung Cancer

Wen Li - Zhejiang University

Yun Xu - Zhejiang University

Jinbiao Zhan - Zhejiang University

View All

Personal Information